Ignite Creation Date:
2025-12-24 @ 2:02 PM
Ignite Modification Date:
2026-01-07 @ 6:49 PM
Study NCT ID:
NCT02799095
Status:
COMPLETED
Last Update Posted:
2025-05-21
First Post:
2016-06-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of the Effects of ALKS 4230 (Nemvaleukin Alfa) on Subjects With Solid Tumors
Sponsor:
Mural Oncology, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-14
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-08-02
Completion Date Type:
ACTUAL
First Submit Date:
2016-06-01
First Submit QC Date:
None
Study First Post Date:
2016-06-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2025-03-21
Results First Submit QC Date:
None
Results First Post Date:
2025-05-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-02
Last Update Post Date:
2025-05-21
Last Update Post Date Type:
ACTUAL